Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022)
Por:
Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Nikolousis, E, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I
Publicada:
1 jun 2022
Ahead of Print:
1 mar 2022
Resumen:
Two members from that institution collaborated in our study but we did not choose the preferred one for the final version of the manuscript. The suggested coauthor is Dr Emmanouil Nikolousis (manos.nikolousis@nhs.net) in place of Shankara Paneesha (shankara.paneesha@nhs.net). Both of them have agreed on this change. The original article has been corrected. © 2022, The Author(s), under exclusive licence to Springer Nature Limited.
Filiaciones:
Zinger, N:
EBMT Data Office Leiden, Leiden, Netherlands
Martino, R:
Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain
Bronze
|